| Description: | The Global Laboratory Initiative (GLI) is a network of international partners dedicated to accelerating and expanding access to quality assured laboratory services in response to the diagnostic challenges of TB, notably HIV-associated and drug-resistant TB. The GLI provides a focus for TB within the framework of a multi-faceted yet integrated approach to laboratory capacity strengthening.
Organizationally, the GLI is one of seven main Working Groups of the Stop TB Partnership (STP) with the GLI secretariat provided by WHO-HQ in Geneva. Functionally, the GLI serves as an independent, technical expert advisory group to WHO, the STP, development agencies and countries. Structurally, the GLI consists of individuals with expertise in multiple disciplines, representing constituencies of stakeholders and/or institutions involved in global, regional and country-level laboratory strengthening.
Similar to other Working Groups, GLI activities are overseen by a Core Group of 10-14 members which acts as a steering committee to guide, evaluate, approve, support and facilitate GLI activities. The Secretariat provides strategic guidance, supports the governance of GLI, facilitates coordination of GLI priority projects, and serves as the focal point for TB laboratory strengthening activities at WHO-HQ. In doing so, the Secretariat works closely with national TB programmes, nongovernmental organizations, technical and funding agencies, WHO offices at country and regional levels, and other STP Working Groups: http://www.stoptb.org/wg/
|
